Molecular evaluation of HBV core gene mutations in asymptomatic HBV infected blood donors in Iran

Soad Ghabeshi1, Ruhollah Baktashi2, Seyed Masoud Hosseini3

  • 1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran Departments of Microbiology, Faculty of Biological Science, Shahid Beheshti University, G.C, Tehran, Iran. z.sharifi@ibto.ir.

Insights

Mutations in the Hepatitis B virus (HBV) core gene are common in Iranian blood donors, leading to reduced HBeAg and immune escape. This impacts chronic hepatitis and liver cancer risk.

Area of Science:

  • Virology
  • Hepatology
  • Molecular Biology

Background:

  • Mutations in Hepatitis B virus (HBV) core promoter and precore regions down-regulate HBeAg.
  • These mutations are linked to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To perform sequence analysis of the HBV core gene in HBsAg-positive blood donors in Iran.
  • To investigate the prevalence and impact of HBV core gene mutations in asymptomatic carriers.

Main Methods:

  • Serological markers (HBsAg, HBeAg, HBeAb, HBcAb) were measured by ELISA.
  • HBV DNA was extracted, and PCR was performed on the core gene.
  • Direct sequencing and line probe assay were used for mutation detection and phylogenetic analysis.

Main Results:

  • 87.8% of HBV DNA-positive donors were HBeAg negative.
  • Precore (PC) and core promoter (BCP) mutants were found in 12% and 55% of donors, respectively.
  • Mutations led to amino acid changes in B cell, T helper, and CTL epitopes, reducing antigenicity.

Conclusions:

  • Hepatitis B virus infected blood donors in Iran frequently exhibit core gene mutations.
  • These mutations reduce HBe and HBc antigenicity, contributing to immune escape in asymptomatic carriers.
  • The findings highlight the role of HBV mutations in the pathogenesis of chronic hepatitis and HCC.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
73
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
16
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.4K